Skip to content

Baxter International BAX APAC — Net Sales

Discontinued — last reported Q2 '23

Similar metrics at other companies

Plexus logo
PLXSAPAC — Net Sales
$651.96M+11.1%
Donaldson Company logo
DCIAPAC — Net Sales
$172.8M+9.2%
McCormick & Company, Incorporated logo
MKCAPAC — Net Sales
$198.6M+5.8%
Stryker logo
SYKAsia Pacific — Net Sales
$541M+7.1%
Boston Scientific logo
BSXAsia Pacific — Net Sales
$803M+14.6%
PPG Industries logo
PPGAsia Pacific — Net Sales
$698M+7.9%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Baxter International’s 10-Q, filed July 27, 2023, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's apac — net sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's APAC — net sales?
Baxter International (BAX) reported APAC — net sales of $638M in Q2 2023.
How has Baxter International's APAC — net sales changed year-over-year?
Baxter International's APAC — net sales decreased by 1.4% year-over-year, from $647M to $638M.
What does APAC — net sales mean?
Represents the total revenue generated from the sale of medical products and services within the Asia-Pacific geographic region. This metric reflects the company's market penetration and demand for its medical instruments and supplies in this specific territory.